QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures
QuVa Pharma recalls specific lots of Methohexital Sodium injection due to failed impurity specifications. Check lot numbers and expiration dates for affected units.
Recall notice
Failed Impurities/Degradation Specifications
Contact the company
What happened, in plain English
QuVa Pharma, Inc. is recalling compounded Methohexital Sodium injections because the product failed impurity and degradation specifications. The recall covers multiple lots distributed nationwide with expiration dates ranging from July to August 2026. The record does not specify the exact health risks associated with these impurities or provide a remedy for consumers. Read more at govinfonow.com/recall/31191-quva-pharma-recalls-methohexital-sodium-due-to-impurity-failures.
Source Summary by GovInfoNow · govinfonow.com/recall/31191-quva-pharma-recalls-methohexital-sodium-due-to-impurity-failures · Updated October 9, 2026 · FDA enforcement record: FDA #D-0664-2026
Cite this page
“QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31191-quva-pharma-recalls-methohexital-sodium-due-to-impurity-failures. Based on FDA recall #D-0664-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0664-2026%22&limit=1).
Why it’s dangerous
The product failed to meet established impurity and degradation specifications. The record does not explain what these impurities are or how they might impact patient safety.
Who’s affected
Patients who have been prescribed this specific compounded drug by healthcare providers and received it through nationwide distribution channels are potentially affected.
How to tell if you have this one
Check your medication for the brand QuVa Pharma, Product code 70092-1310-46, and one of the following lot numbers: 10162261, 10162262, 10162279, 10162280, 10162314, 10162315, 10162465, 10162466, 10162491, 10162492, 10162542, 10162543, 10162559, 10162560, 10162623, 10162624, 10162693, 10162694, 10162735, 10162736, 10162753, 10162754, 10162772, 10162773, 10162791, 10162792, 10162810, 10162811, 10162820, 10162853, 10162854, or 10163046. Verify the expiration date matches the lot (ranging from 07/21/2026 to 08/09/2026).
- Brand
QuVa Pharma- Category
Drug
What to do — step by step
Contact Your Healthcare Provider
Reach out to the doctor or pharmacist who prescribed or dispensed the medication to discuss the recall and next steps.
Do Not Use Affected Lots
If you have any of the listed lot numbers, do not use the product until you have spoken with a medical professional.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 21 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Where was this product sold?
The product was distributed nationwide within the United States.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0664-2026 (June 24, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0664-2026 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.